Patents by Inventor Tom Woiwode

Tom Woiwode has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200383951
    Abstract: Provided are methods of treating patients suffering from or susceptible to at least one symptom of abuse of, dependence on, or withdrawal from at least one substance with Compound A. Also provided are methods of treating at least one phase of substance dependence on at least one substance in patients and certain methods of treating at least one phase of cocaine dependence in patients.
    Type: Application
    Filed: January 7, 2020
    Publication date: December 10, 2020
    Inventors: Tom Woiwode, Mark Moran, Lesley Pickford
  • Patent number: 10561638
    Abstract: Provided are methods of treating patients suffering from or susceptible to at least one symptom of abuse of, dependence on, or withdrawal from at least one substance with Compound A. Also provided are methods of treating at least one phase of substance dependence on at least one substance in patients and certain methods of treating at least one phase of cocaine dependence in patients.
    Type: Grant
    Filed: December 6, 2013
    Date of Patent: February 18, 2020
    Assignee: Biotie Therapies, Inc.
    Inventors: Tom Woiwode, Mark Moran, Lesley Pickford
  • Publication number: 20140099336
    Abstract: Provided are methods of treating patients suffering from or susceptible to at least one symptom of abuse of, dependence on, or withdrawal from at least one substance with Compound A. Also provided are methods of treating at least one phase of substance dependence on at least one substance in patients and certain methods of treating at least one phase of cocaine dependence in patients.
    Type: Application
    Filed: December 6, 2013
    Publication date: April 10, 2014
    Applicant: Biotie Therapies, Inc.
    Inventors: Tom Woiwode, Mark Moran, Lesley Pickford
  • Publication number: 20090082341
    Abstract: Provided are methods of treating post-traumatic stress disorder with 4-hydroxy-4-methyl-piperidine-1-carboxylic acid (4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide. Also provided are methods of improving resilience with 4-hydroxy-4-methyl-piperidine-1-carboxylic acid (4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide. Also provided are methods of diagnosing post-traumatic stress disorder in a patient.
    Type: Application
    Filed: July 23, 2008
    Publication date: March 26, 2009
    Applicant: SYNOSIA THERAPEUTICS
    Inventors: Tom Woiwode, Mark Moran
  • Publication number: 20090054414
    Abstract: Provided are methods of treating post-traumatic stress disorder with rufinamide. Also provided are methods of treating kindling and improving resilience with rufinamide. Also provided are methods of diagnosing post-traumatic stress disorder in a patient by administering to the patient a therapeutically effective amount of rufinamide and assessing at least one of sign, symptom, or symptom cluster of post-traumatic stress disorder; and diagnosing post-traumatic stress disorder in the patient if the rufinamide reduces at least one of sign, symptom, and symptom cluster of post-traumatic stress disorder.
    Type: Application
    Filed: July 23, 2008
    Publication date: February 26, 2009
    Applicant: SYNOSIA THERAPEUTICS
    Inventors: Tom Woiwode, Mark Moran
  • Publication number: 20090054403
    Abstract: Provided are methods of treating a patient diagnosed with post-traumatic stress disorder, by administering to the patient a therapeutically effective amount of Compound A. Also provided are methods of improving resilience in a patient by administering a therapeutically effective amount of Compound A. Also provided are methods of diagnosing post-traumatic stress disorder in a patient by administering to the patient a therapeutically effective amount of Compound A and assessing at least one of sign, symptom, or symptom cluster of post-traumatic stress disorder; and diagnosing post-traumatic stress disorder in the patient if the Compound A reduces at least one of sign, symptom, and symptom cluster of post-traumatic stress disorder.
    Type: Application
    Filed: July 23, 2008
    Publication date: February 26, 2009
    Applicant: SYNOSIA THERAPEUTICS
    Inventors: Tom Woiwode, Mark Moran
  • Publication number: 20090041800
    Abstract: Provided are methods of treating patients suffering from or susceptible to at least one symptom of abuse of, dependence on, or withdrawal from at least one substance with Compound A. Also provided are methods of treating at least one phase of substance dependence on at least one substance in patients and certain methods of treating at least one phase of cocaine dependence in patients.
    Type: Application
    Filed: August 6, 2008
    Publication date: February 12, 2009
    Applicant: SYNOSIA THERAPEUTICS, INC.
    Inventors: Tom Woiwode, Mark Moran, Lesley Pickford